BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34498388)

  • 21. Pharmacokinetics of a fixed-dose combination of atorvastatin and metformin extended release versus concurrent administration of individual formulations: a randomized, open-label, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study.
    Kandhwal K; Dey S; Nazarudheen S; Arora R; Reyar S; Thudi NR; Monif T; Singh MK; Rao S
    Clin Drug Investig; 2011 Dec; 31(12):853-63. PubMed ID: 21919543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic properties and bioequivalence of two sulfadoxine/pyrimethamine fixed-dose combination tablets: a parallel-design study in healthy Chinese male volunteers.
    Liu YM; Zhang KE; Liu Y; Zhang HC; Song YX; Pu HH; Lu C; Liu GY; Jia JY; Zheng QS; Zhu JM; Yu C
    Clin Ther; 2012 Nov; 34(11):2212-20. PubMed ID: 23084093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits of a fixed-dose combination of bisoprolol and amlodipine in the treatment of hypertension in daily practice: results of more than 4000 patients.
    Czarnecka D; Koch EM; Gottwald-Hostalek U
    Curr Med Res Opin; 2015 May; 31(5):875-81. PubMed ID: 25753136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence study of two perindopril tert-butylamine tablet formulations in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial.
    Li Q; Hao Z; Yu Y; Tang Y
    Biomed Pharmacother; 2021 Mar; 135():111221. PubMed ID: 33433351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioequivalence study of two formulations of bisoprolol fumarate film-coated tablets in healthy subjects.
    Tjandrawinata RR; Setiawati E; Yunaidi DA; Santoso ID; Setiawati A; Susanto LW
    Drug Des Devel Ther; 2012; 6():311-6. PubMed ID: 23139624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioequivalence of saxagliptin/metformin immediate release (IR) fixed-dose combination tablets and single-component saxagliptin and metformin IR tablets in healthy adult subjects.
    Upreti VV; Keung CF; Boulton DW; Chang M; Li L; Tang A; Hsiang BC; Quamina-Edghill D; Frevert EU; Lacreta FP
    Clin Drug Investig; 2013 May; 33(5):365-74. PubMed ID: 23549864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Acetylsalicylic Acid in Fixed-Dose Combination with Clopidogrel Versus Enteric Aspirin in Chinese Subjects Under Fasting Conditions: A Phase 1, Open-Label, Randomized, Crossover Study.
    Wang L; Di Y; Guo T; Ming JE; Kong F; Yin H; Zhang L; Xie F; Yang N; Ping C; Li Y; Hou J
    Adv Ther; 2020 Jun; 37(6):2696-2709. PubMed ID: 32418143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions.
    Wu L; Xu C; Wu G; Zhou H; Lv D; Zhai Y; Huang Y; Tang W; Li F; Shentu J
    Drug Des Devel Ther; 2019; 13():3331-3342. PubMed ID: 31571834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of food on the pharmacokinetics of canagliflozin/metformin (150/1,000 mg) immediate-release fixed-dose combination tablet in healthy participants.
    Murphy J; Wang SS; Stieltjes H; Wajs E; Devineni D
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):256-64. PubMed ID: 25546166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult subjects.
    Boulton DW; Smith CH; Li L; Huang J; Tang A; LaCreta FP
    Clin Drug Investig; 2011; 31(9):619-30. PubMed ID: 21819160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linagliptin fixed-dose combination with metformin is bioequivalent to co-administration of linagliptin and metformin as individual tablets.
    Buschke S; Ring A; Friedrich C; Metzmann K; Meinicke T
    Int J Clin Pharmacol Ther; 2014 Jul; 52(7):537-48. PubMed ID: 24755123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioequivalence study of 10 mg ramipril tablets in healthy Thai volunteers.
    Chatsiricharoenkul S; Thangboonjit W; Pongnarin P; Konhan K; Sathirakul K; Kongpatanakul S
    J Med Assoc Thai; 2011 Oct; 94(10):1260-6. PubMed ID: 22145513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fed and Fasted Single-dose Assessment of Bioequivalence of Dapagliflozin and Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.
    Boulton DW; Chang M; Griffen SC; Kitaura C; Lubin S; Pollack A; LaCreta F
    Clin Ther; 2016 Jan; 38(1):99-109. PubMed ID: 26682500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioequivalence of a Fixed-Dose Combination Tablet of the Complete Two-Drug Regimen of Dolutegravir and Rilpivirine for Treatment of HIV-1 Infection.
    Mehta R; Wolstenholme A; Di Lullo K; Fu C; Joshi S; Crauwels H; Givens N; Vanveggel S; Wynne B; Adkison K
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioequivalence Study of Amitriptyline Hydrochloride Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
    Zhai Y; Wu L; Zheng Y; Wu M; Huang Y; Huang Q; Shentu J; Zhao Q; Liu J
    Drug Des Devel Ther; 2020; 14():3131-3142. PubMed ID: 32801649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized trial in healthy subjects to assess the bioequivalence of an atazanavir/cobicistat fixed-dose combination tablet versus administration as separate agents.
    Sevinsky H; Tao X; Wang R; Ravindran P; Sims K; Xu X; Jariwala N; Bertz R
    Antivir Ther; 2015; 20(5):493-500. PubMed ID: 25361436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
    Li W; Wang Y; Pei Y; Xia Y
    Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioequivalence for a Fixed-Dose Combination Formulation of Bazedoxifene and Cholecalciferol Compared With the Corresponding Single Entities Given Together.
    Yun JN; Kan HS; Yeun JS; Kim JH; Lee M; Kim N; Oh TY; Nam SK; Choi YS; Kwon IS; Hoe KL; Hong JH
    Clin Pharmacol Drug Dev; 2021 Aug; 10(8):850-858. PubMed ID: 34190419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the bioavailability and tolerability of fixed-dose combination glimepiride/metformin 2/500-mg tablets versus separate tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy Korean volunteers.
    Gu N; Kim BH; Rhim H; Chung JY; Kim JR; Shin HS; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2010 Jul; 32(7):1408-18. PubMed ID: 20678687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical results with bisoprolol 2.5 mg/hydrochlorothiazide 6.25 mg combination in systolic hypertension in the elderly.
    Benetos A; Adamopoulos C; Argyriadis P; Bean K; Consoli S; Safar M
    J Hypertens Suppl; 2002 Feb; 20(1):S21-5. PubMed ID: 11996196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.